Alkermes is a fully integrated biopharmaceutical company headquartered in Dublin, Ireland, with R&D and manufacturing facilities in the US.
With $1.5bn in annual revenue, Alkermes has focused for more than 30 years on developing innovative treatments for psychiatric and neurological disorders.
At a time when 40% of procurement teams said manual and inefficient processes are holding them back, the company turned to JAGGAER to improve spend visibility and create standardised workflows across departments and sites.
The result has increased usability and brought a 23% reduction in purchase order (PO) processing costs and a 32% reduction in cycle times.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.